Over the last few years, the small animal imaging market witnessed significant advancements in terms of the product development and commercialization (such as multi-modality imaging systems, trimodality imaging systems, and magnetic particle imaging systems). Technological advancements in the field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, growing number of public-private initiatives and funding to support preclinical researches, and development of low cost & affordable preclinical imaging systems are some of the major driving factors for the global small animal imaging market.
As of 2016, developing Asia-Pacific countries such as China and India are emerging as new revenue-generating destinations for prominent market players. Continuous government support for pharmaceutical and biotechnology R&D, increasing public-private investments to support radioisotope production, rising number of translational research activities, and evolving regulatory scenario across major Asian countries are expected to offer high growth opportunities for market players in the Asia-Pacific region.
The magnetic particle imaging offers high growth opportunities for market players in the small animal imaging systems market. Growth in the magnetic particle imaging segment can primarily be attributed to increasing adoption of technologically advanced magnetic imaging systems in life science research studies owing to the advantages offered by it. The magnetic particle imaging technology provides high quality deep tissue imaging with no diminution of signal with depth, and imaging of blood circulation system and vascular system of animal body. Companies such as Bruker Corporation (U.S.) and Magnetic Insights (U.S.) have been focusing towards this high-growth market to gain more profits and increase their shares in the small animal imaging market in the coming years.
